KRISTINE BATISTA: Open Payments
NPI 1225744725 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 33 payments from 13 companies in 2025. Trend: 2023 $1,081 · 2024 $89 · 2025 $815
Food & beverage: $797Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $342 |
| Insmed, Inc. | 7 | $158 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| Verona Pharma, Inc. | 2 | $44 |
| ANI Pharmaceuticals, Inc. | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Baxter Healthcare | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| SANOFI PASTEUR INC. | 1 | $16 |
Products named: NUCALA, Arikayce, DUPIXENT, Ohtuvayre, PURIFIED CORTROPHIN GEL, TRELEGY ELLIPTA, GLASSIA, WINREVAIR.
Industry payments across FL — which companies pay providers there.
